A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration
Authors:
Open Access
- 7 June 2005
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 21 (s2) , 111-115
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Early decrease in serum IV-7S levels during IFN treatment predicts anti-fibrogenic effect in nonresponders with chronic hepatitis CJournal of Gastroenterology, 2004
- Endoscopic mucosal resectionGastrointestinal Endoscopy, 2003
- Endoscopic Mucosal ResectionEndoscopy, 2001
- New Endoscopic Treatment for Intramucosal Gastric Tumors Using an Insulated-Tip Diathermic KnifeEndoscopy, 2001
- Endoscopic mucosal resection for treatment of early gastric cancerGut, 2001
- Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast‐dissolving tablets to fasting healthy volunteersAlimentary Pharmacology & Therapeutics, 1997
- In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.Alimentary Pharmacology & Therapeutics, 1997
- The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric PHCurrent Therapeutic Research, 1996
- Comparison of acid inhibition by either oral high‐dose ranitidine or omeprazoleAlimentary Pharmacology & Therapeutics, 1994
- Endoscopic Resection of Early Gastric CancerEndoscopy, 1993